JFG
Jefferies Financial Group Portfolio holdings
AUM
$6.06B
1-Year Return
9.37%
This Quarter Return
+4.86%
1 Year Return
+9.37%
3 Year Return
+16.02%
5 Year Return
+51.04%
10 Year Return
+258.41%
AUM
$6.37B
AUM Growth
+$2.36B
(+59%)
Cap. Flow
+$1.67B
Cap. Flow
% of AUM
26.17%
Top 10 Holdings %
Top 10 Hldgs %
35.37%
Holding
1,607
New
410
Increased
344
Reduced
245
Closed
294
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$942M |
| 2 |
Surgery Partners
SGRY
|
$145M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
$89.5M |
| 4 |
LCA
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
|
$65M |
| 5 |
Invesco Zacks Mid-Cap ETF
CZA
|
$52.5M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$72.5M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$71.9M |
| 3 |
FRGI
Fiesta Restaurant Group, Inc.
FRGI
|
$44.5M |
| 4 |
Apple
AAPL
|
$43.8M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$37.1M |
Sector Composition
| 1 | Healthcare | 15.25% |
| 2 | Technology | 9.64% |
| 3 | Industrials | 6.66% |
| 4 | Financials | 5.96% |
| 5 | Consumer Discretionary | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Occidental Petroleum
OXY
$45.2B
| $2.31M | 0.02% |
38,701
-89,465
| -70% | -$5.34M |
|
377
Air Lease Corp
AL
$7.12B
| $2.31M | 0.02% |
+55,000
| New | +$2.31M |
|
378
Relay Therapeutics
RLAY
$710M
| $2.3M | 0.02% |
209,263
-153,346
| -42% | -$1.69M |
|
379
Archer Daniels Midland
ADM
$30.2B
| $2.29M | 0.01% |
+31,700
| New | +$2.29M |
|
380
United Therapeutics
UTHR
$18.1B
| $2.28M | 0.01% |
+10,385
| New | +$2.28M |
|
381
Watsco
WSO
$16.6B
| $2.28M | 0.01% |
+5,322
| New | +$2.28M |
|
382
InterDigital
IDCC
$7.43B
| $2.27M | 0.01% |
+20,879
| New | +$2.27M |
|
383
Equity Residential
EQR
$25.5B
| $2.26M | 0.01% |
+36,963
| New | +$2.26M |
|
384
Marriott Vacations Worldwide
VAC
$2.73B
| $2.25M | 0.01% |
26,557
+24,540
| +1,217% | +$2.08M |
|
385
TransDigm Group
TDG
$71.6B
| $2.24M | 0.01% |
2,212
+626
| +39% | +$633K |
|
386
Dynatrace
DT
$15.1B
| $2.23M | 0.01% |
40,845
-9,827
| -19% | -$537K |
|
387
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.44B
| $2.23M | 0.01% |
23,979
-6,465
| -21% | -$602K |
|
388
Omnicom Group
OMC
$15.4B
| $2.23M | 0.01% |
25,800
| – | – |
|
389
Qualys
QLYS
$4.87B
| $2.23M | 0.01% |
+11,371
| New | +$2.23M |
|
390
Carlyle Group
CG
$23.1B
| $2.2M | 0.01% |
53,990
+26,835
| +99% | +$1.09M |
|
391
Cassava Sciences
SAVA
$104M
| $2.2M | 0.01% |
97,562
-139,463
| -59% | -$3.14M |
|
392
iShares Russell Mid-Cap Value ETF
IWS
$14.1B
| $2.18M | 0.01% |
+18,751
| New | +$2.18M |
|
393
MetLife
MET
$52.9B
| $2.17M | 0.01% |
32,800
-78,400
| -71% | -$5.18M |
|
394
C3.ai
AI
$2.15B
| $2.15M | 0.01% |
+75,000
| New | +$2.15M |
|
395
Fortinet
FTNT
$60.4B
| $2.14M | 0.01% |
36,562
-94,231
| -72% | -$5.52M |
|
396
Pacira BioSciences
PCRX
$1.19B
| $2.14M | 0.01% |
63,361
+28,699
| +83% | +$968K |
|
397
Cytokinetics
CYTK
$6.34B
| $2.1M | 0.01% |
+25,208
| New | +$2.1M |
|
398
Revolution Medicines
RVMD
$7.57B
| $2.1M | 0.01% |
+73,354
| New | +$2.1M |
|
399
United Airlines
UAL
$34.5B
| $2.09M | 0.01% |
50,614
-24,361
| -32% | -$1.01M |
|
|
ITCI
400
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.08M | 0.01% |
29,000
+28,840
| +18,025% | +$2.07M |
|